MXPA03010596A - Preparaciones granuladas de gaboxadol. - Google Patents
Preparaciones granuladas de gaboxadol.Info
- Publication number
- MXPA03010596A MXPA03010596A MXPA03010596A MXPA03010596A MXPA03010596A MX PA03010596 A MXPA03010596 A MX PA03010596A MX PA03010596 A MXPA03010596 A MX PA03010596A MX PA03010596 A MXPA03010596 A MX PA03010596A MX PA03010596 A MXPA03010596 A MX PA03010596A
- Authority
- MX
- Mexico
- Prior art keywords
- gaboxadol
- granular preparations
- preparation
- granular
- dosage forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La presente invencion se relaciona con un producto granulado que contiene gaboxadol como sal de adicion de acido, con un proceso de granulacion en fusion para la preparacion del mismo y con formas de dosificacion unitaria farmaceuticas macizas preparadas con dicha preparacion granulada de gaboxadol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200100817 | 2001-05-21 | ||
| PCT/DK2002/000332 WO2002094225A1 (en) | 2001-05-21 | 2002-05-17 | Granular preparations of gaboxadol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03010596A true MXPA03010596A (es) | 2004-03-09 |
Family
ID=8160520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03010596A MXPA03010596A (es) | 2001-05-21 | 2002-05-17 | Preparaciones granuladas de gaboxadol. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20040157876A1 (es) |
| EP (1) | EP1389091A1 (es) |
| JP (1) | JP2004530695A (es) |
| KR (1) | KR20030097890A (es) |
| CN (1) | CN1511026A (es) |
| AR (1) | AR033896A1 (es) |
| AU (1) | AU2002338855B2 (es) |
| BG (1) | BG108441A (es) |
| BR (1) | BR0209834A (es) |
| CA (1) | CA2447603A1 (es) |
| CZ (1) | CZ20033269A3 (es) |
| EA (2) | EA009731B1 (es) |
| HR (1) | HRP20030950A2 (es) |
| HU (1) | HUP0400051A2 (es) |
| IL (1) | IL158733A0 (es) |
| IS (1) | IS7020A (es) |
| ME (1) | MEP6308A (es) |
| MX (1) | MXPA03010596A (es) |
| NO (1) | NO20035146D0 (es) |
| NZ (1) | NZ547636A (es) |
| PL (1) | PL366541A1 (es) |
| SK (1) | SK15542003A3 (es) |
| UA (1) | UA80092C2 (es) |
| WO (1) | WO2002094225A1 (es) |
| YU (1) | YU92103A (es) |
| ZA (1) | ZA200308594B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001022941A1 (en) * | 1999-09-28 | 2001-04-05 | H. Lundbeck A/S | Melt granulated composition and modified release dosage form prepared from said composition |
| PT1641456E (pt) | 2003-06-25 | 2010-06-01 | Lundbeck & Co As H | Gaboxadol para o tratamento de depressão e outros distúrbios afectivos |
| TW200528098A (en) * | 2003-12-18 | 2005-09-01 | Lundbeck & Co As H | Treatment of insomnia in human patients |
| GB0402118D0 (en) | 2004-01-30 | 2004-03-03 | Merck Sharp & Dohme | Polymorphic forms of a GABAA agonist |
| EP1848420A4 (en) | 2005-01-28 | 2008-01-23 | Merck & Co Inc | POLYMORPHIC FORMS OF A GABAA AGONIST |
| EP1906953A4 (en) * | 2005-04-29 | 2009-05-20 | Lundbeck & Co As H | FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL |
| CA2725356C (en) * | 2008-05-30 | 2018-10-16 | Psychogenics, Inc. | Use of eltoprazine for improving symptoms of cognitive impairment associated with non-adhd neurological and mental disorders |
| EP2334299A1 (en) * | 2008-09-01 | 2011-06-22 | H. Lundbeck A/S | Pharmaceutical composition comprising gaboxadol and an inhibitor of patl or oat |
| CA2859174C (en) | 2011-12-12 | 2019-03-05 | Orbis Biosciences, Inc. | Sustained release particle formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4315934A (en) * | 1979-09-24 | 1982-02-16 | Sandoz Ltd. | Organic compounds |
| DE19525598C2 (de) * | 1995-07-13 | 1997-09-25 | Max Planck Gesellschaft | Schlafmittel |
| US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
| WO2001022941A1 (en) * | 1999-09-28 | 2001-04-05 | H. Lundbeck A/S | Melt granulated composition and modified release dosage form prepared from said composition |
| US6375982B1 (en) * | 2000-07-05 | 2002-04-23 | Capricorn Pharma, Inc. | Rapid-melt semi-solid compositions, methods of making same and method of using same |
-
2002
- 2002-05-17 BR BR0209834-2A patent/BR0209834A/pt not_active IP Right Cessation
- 2002-05-17 US US10/478,983 patent/US20040157876A1/en not_active Abandoned
- 2002-05-17 MX MXPA03010596A patent/MXPA03010596A/es not_active Application Discontinuation
- 2002-05-17 HU HU0400051A patent/HUP0400051A2/hu unknown
- 2002-05-17 KR KR10-2003-7015136A patent/KR20030097890A/ko not_active Application Discontinuation
- 2002-05-17 IL IL15873302A patent/IL158733A0/xx unknown
- 2002-05-17 WO PCT/DK2002/000332 patent/WO2002094225A1/en active Application Filing
- 2002-05-17 CZ CZ20033269A patent/CZ20033269A3/cs unknown
- 2002-05-17 SK SK1554-2003A patent/SK15542003A3/sk not_active Application Discontinuation
- 2002-05-17 EA EA200301282A patent/EA009731B1/ru not_active IP Right Cessation
- 2002-05-17 AR ARP020101839A patent/AR033896A1/es unknown
- 2002-05-17 AU AU2002338855A patent/AU2002338855B2/en not_active Ceased
- 2002-05-17 YU YU92103A patent/YU92103A/sh unknown
- 2002-05-17 UA UA20031110120A patent/UA80092C2/uk unknown
- 2002-05-17 CA CA002447603A patent/CA2447603A1/en not_active Abandoned
- 2002-05-17 CN CNA028104587A patent/CN1511026A/zh active Pending
- 2002-05-17 ME MEP-63/08A patent/MEP6308A/xx unknown
- 2002-05-17 JP JP2002590944A patent/JP2004530695A/ja active Pending
- 2002-05-17 PL PL02366541A patent/PL366541A1/xx not_active Application Discontinuation
- 2002-05-17 NZ NZ547636A patent/NZ547636A/en unknown
- 2002-05-17 EA EA200700703A patent/EA200700703A1/ru unknown
- 2002-05-17 EP EP02742834A patent/EP1389091A1/en not_active Ceased
-
2003
- 2003-11-04 ZA ZA200308594A patent/ZA200308594B/en unknown
- 2003-11-10 IS IS7020A patent/IS7020A/is unknown
- 2003-11-19 NO NO20035146A patent/NO20035146D0/no not_active Application Discontinuation
- 2003-11-21 HR HR20030950A patent/HRP20030950A2/hr not_active Application Discontinuation
- 2003-12-12 BG BG108441A patent/BG108441A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20030950A2 (en) | 2005-08-31 |
| HUP0400051A2 (hu) | 2004-04-28 |
| EA200301282A1 (ru) | 2004-04-29 |
| NO20035146L (no) | 2003-11-19 |
| CZ20033269A3 (en) | 2004-03-17 |
| IS7020A (is) | 2003-11-10 |
| NZ547636A (en) | 2008-03-28 |
| WO2002094225A1 (en) | 2002-11-28 |
| SK15542003A3 (sk) | 2004-05-04 |
| CN1511026A (zh) | 2004-07-07 |
| CA2447603A1 (en) | 2002-11-28 |
| UA80092C2 (en) | 2007-08-27 |
| EP1389091A1 (en) | 2004-02-18 |
| ZA200308594B (en) | 2004-11-04 |
| JP2004530695A (ja) | 2004-10-07 |
| IL158733A0 (en) | 2004-05-12 |
| BG108441A (en) | 2005-02-28 |
| NO20035146D0 (no) | 2003-11-19 |
| EA200700703A1 (ru) | 2007-08-31 |
| MEP6308A (xx) | 2010-02-10 |
| EA009731B1 (ru) | 2008-02-28 |
| BR0209834A (pt) | 2004-06-15 |
| AR033896A1 (es) | 2004-01-07 |
| PL366541A1 (en) | 2005-02-07 |
| YU92103A (sh) | 2006-05-25 |
| KR20030097890A (ko) | 2003-12-31 |
| US20040157876A1 (en) | 2004-08-12 |
| AU2002338855B2 (en) | 2007-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1050526A1 (en) | New a-amino acid compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
| WO2004082615A3 (en) | A process for preparing sustained release tablets | |
| WO2004055006A8 (en) | Novel compounds having selective inhibiting effect at gsk3 | |
| IL164857A (en) | 1-thia-4,8,diaza-spiro[4.5]decan-3-one compounds, process for preparation thereof and pharmaceutical compositions comprising them | |
| HUP0105437A3 (en) | Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them | |
| AU7642001A (en) | Novel $G(Y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. | |
| MXPA04003636A (es) | Composiciones farmaceuticas que comprenden acido micofenolico o sal de micofenolato. | |
| HUP0102813A3 (en) | New betha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it | |
| WO2003087050A3 (fr) | Sel de perindopril et les compositions pharmaceutiques qui le contiennent | |
| IS6511A (is) | Lyfjaefnablöndur sem innihalda sykurfitusýru estera til að stýra losun á virkum innihaldsefnum | |
| PL365379A1 (en) | Novel compounds having hypolipedemic, hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them | |
| YU92103A (sh) | Granulirani preparati gaboksadola | |
| AU2003202719A1 (en) | Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them. | |
| WO2001000617A3 (en) | Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same | |
| FR2819720B1 (fr) | Nouveaux comprimes de fenofibrate | |
| WO2005046727A3 (en) | Ibuprofen-containing soft gelatin capsules | |
| AU2003231920A1 (en) | Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0600084A2 (en) | Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient | |
| AU2002306687A1 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201024A3 (en) | Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them | |
| UA81610C2 (ru) | Изохинолиновые соединения, способ их получения и фармацевтическая композиция, которая их содержит | |
| AU2001252825A1 (en) | Thieno(2,3-d)pyrimidinediones and their use as pharmaceuticals | |
| HU0100751D0 (en) | New aryl or heteroaryl quinolinylphosphonic acid derivatives, process for their preparation and pharmaceutical compositions containing them | |
| EP1176149A4 (en) | NEW GYMNEMIC ACID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |